June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Effect of Photodynamic Therapy on Choroidal Indices in Patients with Central Serous Chorioretinopathy
Author Affiliations & Notes
  • Muhammad Hassan
    Ophthalmology, Stanford University Department of Ophthalmology, Palo Alto, California, United States
  • Sarakshi Mahajan
    Ophthalmology, Stanford University Department of Ophthalmology, Palo Alto, California, United States
  • Maria Soledad Ormaechea
    Ophthalmology, Stanford University Department of Ophthalmology, Palo Alto, California, United States
  • Rupesh V Agrawal
    Tan Tock Seng Hospital, Singapore, Singapore
  • Quan Dong Nguyen
    Ophthalmology, Stanford University Department of Ophthalmology, Palo Alto, California, United States
  • Ruwan Amila Silva
    Ophthalmology, Stanford University Department of Ophthalmology, Palo Alto, California, United States
  • Footnotes
    Commercial Relationships   Muhammad Hassan, None; Sarakshi Mahajan, None; Maria Ormaechea, None; Rupesh Agrawal, None; Quan Nguyen, AbbVie (S), Bayer (S), Genentech (S), Regenron (S), Research to Prevent Blindness (R), Santen (S); Ruwan Silva, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2845. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Muhammad Hassan, Sarakshi Mahajan, Maria Soledad Ormaechea, Rupesh V Agrawal, Quan Dong Nguyen, Ruwan Amila Silva; Effect of Photodynamic Therapy on Choroidal Indices in Patients with Central Serous Chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2845.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To report the effect of photodynamic therapy (PDT) on choroidal indices in patients with central serous chorioretinopathy (CSC).

Methods : Patients with a confirmed diagnosis of CSC managed at a tertiary care center, who underwent PDT with subsequent resolution of the subretinal fluid were analyzed. The PDT procedure was performed by the same physician. Enhanced depth imaging optical coherence tomography (EDI-OCT) scans of the study population were captured and analyzed before and after the resolution of the subretinal fluid. 5-line high definition scans centered on the foveal center were utilized. Image J (Version 1.52a, NIH) was utilized to segment the choroidal layer in each of the b-scan to evaluate: 1) Subfoveal Choroidal Thickness (SFCT); 2) Choroidal Volume (CV); and 3) Choroidal Vascularity Index (CVI). Multiple linear regression was used to compare the choroidal indices at the two time points.

Results : Six patients with a confirmed diagnosis of CSC that demonstrated resolution of subretinal fluid after receiving PDT were analyzed. The mean age of the study population was 62 (Range: 45-68 years). Five (83.33%) patients were male. The mean (SD) SFCT, CV, and CVI before the PDT of the study population was 310.35 (97.84), 1.64 (0.35), and 0.648 (0.009), respectively. Following the resolution of the subretinal fluid, the mean (SD) SFCT, CV, and CVI of the study population were 240.43 (95.25), 1.61 (0.31), and 0.649 (0.008), respectively. Multiple linear regression demonstrated a statistically significant decrease in SFCT (R2=91, p=0.045), CV (R2=97, p=0.021) and increase in CVI (R2=98, p=0.015) after PDT.

Conclusions : PDT is associated with significant changes in the choroidal structure in CSC patients. Choroidal indices may be employed to monitor disease progression.

This is a 2021 ARVO Annual Meeting abstract.

 

Figure 1: Mean changes in subfoveal choroidal thickness (SFCT), choroidal volume (CV), and choroidal vascularity index (CVI) pre- and post-photodynamic therapy (PDT) in patients with central serous chorioretinopathy (CSC)

Figure 1: Mean changes in subfoveal choroidal thickness (SFCT), choroidal volume (CV), and choroidal vascularity index (CVI) pre- and post-photodynamic therapy (PDT) in patients with central serous chorioretinopathy (CSC)

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×